Disclosure Of Cash Flow Statement [Text Block]

Oxford Biomedica PLC - Filing #5873328

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
60 ,65 0 GBP
103, 71 6 GBP
141 ,2 85 GBP
Disclosure of information that enables users of financial statements to evaluate changes in liabilities arising from financing activities [text block]
Disclosure of reconciliation of liabilities arising from financing activities [text block]
Income taxes paid (refund) [abstract]
Income taxes paid (refund), classified as operating activities
- GBP
7,5 10 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.